Home Biosimilar Antibodies Protein Tyrosine Kinase EGFR antibody Imgatuzumab (Anti-ERBB1 / EGFR / HER1) For research use only.
Not for use in humans.

Imgatuzumab (Anti-ERBB1 / EGFR / HER1)

Synonyms:

Imgatuzumab (Anti-ERBB1 / EGFR / HER1) is a glycoengineered monoclonal antibody directed against the epidermal growth factor receptor (EGFR) with potential antineoplastic activity. MW: 145.28 KD.

Imgatuzumab (Anti-ERBB1 / EGFR / HER1)

Purity & Quality Control

≥99

Choose Selective EGFR Inhibitors

Biological Activity

Description Imgatuzumab (Anti-ERBB1 / EGFR / HER1) is a glycoengineered monoclonal antibody directed against the epidermal growth factor receptor (EGFR) with potential antineoplastic activity. MW: 145.28 KD.

Product Details

CAS No. 959963-46-3
Molecular Weight 145.28
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Imgatuzumab (Anti-ERBB1 / EGFR / HER1) | Imgatuzumab (Anti-ERBB1 / EGFR / HER1) supplier | purchase Imgatuzumab (Anti-ERBB1 / EGFR / HER1) | Imgatuzumab (Anti-ERBB1 / EGFR / HER1) cost | Imgatuzumab (Anti-ERBB1 / EGFR / HER1) manufacturer | order Imgatuzumab (Anti-ERBB1 / EGFR / HER1) | Imgatuzumab (Anti-ERBB1 / EGFR / HER1) distributor